-
公开(公告)号:US20240043427A1
公开(公告)日:2024-02-08
申请号:US17997594
申请日:2021-04-29
Applicant: Gilead Sciences, Inc.
Inventor: Mark J. Bartlett , Gregory F. Chin , Michael O. Clarke , Jennifer L. Cosman , Deeba Ensan , Bindu Goyal , Stephen Ho , Hon C. Hui , Richard L. Mackman , Michael R. Mish , Scott D. Schroeder , Nathan D. Shapiro , Dustin S. Siegel , Doris T. Tang , Hai Yang
IPC: C07D487/04 , C07D519/00 , A61K45/06 , C07K16/28
CPC classification number: C07D487/04 , C07D519/00 , C07K16/2827 , C07K16/2818 , A61K45/06
Abstract: The present disclosure provides pyrimidine dione compounds, and pharmaceutical compositions thereof, for treating cancer, including solid tumors. The compounds can be used alone or in combination with other anti-cancer agents.
-
公开(公告)号:US12110294B2
公开(公告)日:2024-10-08
申请号:US17243911
申请日:2021-04-29
Applicant: Gilead Sciences, Inc.
Inventor: Mark J. Bartlett , Gregory F. Chin , Michael O. Clarke , Jennifer L. Cosman , Deeba Ensan , Bindu Goyal , Stephen Ho , Hon C. Hui , Richard L. Mackman , Michael R. Mish , Scott D. Schroeder , Nathan D. Shapiro , Dustin S. Siegel , Doris T. Tang , Hai Yang
IPC: C07D487/04 , A61K45/06 , C07D519/00 , C07K16/28
CPC classification number: C07D487/04 , A61K45/06 , C07D519/00 , C07K16/2818 , C07K16/2827
Abstract: The present disclosure provides pyrimidine dione compounds of Formula I
and pharmaceutical compositions thereof, for treating cancer, including solid tumors either-used alone or in combination with other anti-cancer agents.-
公开(公告)号:US20230039553A1
公开(公告)日:2023-02-09
申请号:US17243911
申请日:2021-04-29
Applicant: Gilead Sciences, Inc.
Inventor: Mark J. Bartlett , Gregory F. Chin , Michael O. Clarke , Jennifer L. Cosman , Deeba Ensan , Bindu Goyal , Stephen Ho , Hon C. Hui , Richard L. Mackman , Michael R. Mish , Scott D. Schroeder , Nathan D. Shapiro , Dustin S. Siegel , Doris T. Tang , Hai Yang
IPC: C07D487/04 , C07D519/00 , A61K45/06 , C07K16/28
Abstract: The present disclosure provides pyrimidine dione compounds, and pharmaceutical compositions thereof, for treating cancer, including solid tumors. The compounds can be used alone or in combination with other anti-cancer agents.
-
公开(公告)号:US20240279186A1
公开(公告)日:2024-08-22
申请号:US18428316
申请日:2024-01-31
Applicant: Gilead Sciences, Inc.
Inventor: Mark J. Bartlett , Gregory F. Chin , Michael O. Clarke , Jennifer L. Cosman , Deeba Ensan , Bindu Goyal , Stephen Ho , Richard L. Mackman , Michael R. Mish , Dustin S. Siegel , Kyle C. Tamshen , Hai Yang
IPC: C07D247/00
CPC classification number: C07D247/00
Abstract: Provided herein is A compound of Formula I:
or a pharmaceutically acceptable salt thereof, wherein the various substituents are described herein.-
公开(公告)号:US11919869B2
公开(公告)日:2024-03-05
申请号:US18050404
申请日:2022-10-27
Applicant: Gilead Sciences, Inc.
Inventor: Mark J. Bartlett , Gregory F. Chin , Michael O. Clarke , Jennifer L Cosman , Deeba Ensan , Bindu Goyal , Stephen Ho , Richard L Mackman , Michael R. Mish , Dustin S. Siegel , Kyle C. Tamshen , Hai Yang
IPC: C07D247/00
CPC classification number: C07D247/00
Abstract: Provided herein is A compound of Formula I:
or a pharmaceutically acceptable salt thereof, wherein the various substituents are described herein.-
公开(公告)号:US20230183189A1
公开(公告)日:2023-06-15
申请号:US18050404
申请日:2022-10-27
Applicant: Gilead Sciences, Inc.
Inventor: Mark J. Bartlett , Gregory F. Chin , Michael O. Clarke , Jennifer L. Cosman , Deeba Ensan , Bindu Goyal , Stephen Ho , Richard L. Mackman , Michael R. Mish , Dustin S. Siegel , Kyle C. Tamshen , Hai Yang
IPC: C07D247/00
CPC classification number: C07D247/00
Abstract: Provided herein is A compound of Formula I:
or a pharmaceutically acceptable salt thereof, wherein the various substituents are described herein.
-
-
-
-
-